Jacobs Mitchell, Demas Nicholas, Hemesath Angela, Turski Christopher, Fowler Nicholas, Chadwell John Benjamin, Dupont Alec, Kupper Victoria, Acharya Kishor, Robbins Sarah, Heier Kory, Maldonado Ramiro
Department of Ophthalmology and Visual Sciences, University of Kentucky, Lexington, Kentucky, USA.
Department Eye Center, Duke University, Durham, North Carolina, USA.
J Ophthalmol. 2024 Oct 28;2024:5597188. doi: 10.1155/2024/5597188. eCollection 2024.
Caffeine, the most widely consumed psychoactive drug globally, has been associated with vascular changes in various organs, including the retina. Researchers have reported vascular constriction in the retina in response to caffeine, although data on its effects remain limited and somewhat contradictory. Further research is needed to clarify the specific impact of caffeine on retinal blood vessels and its potential implications for ocular health. To investigate the effects of 200 mg of caffeine on systolic and diastolic blood pressure (SBP and DBP) and retinal vessel density (VD) assessed by optical coherence tomography angiography (OCTA). Prospective randomized, double-blind placebo-controlled, IRB-approved study in 59 healthy low caffeine users (< 136 mg of caffeine daily). Baseline 3 × 3 and 6 × 6 mm OCTA scans centered on the fovea as well as a 6 × 6 mm scans centered on the optic nerve head (ONH) were obtained. Participants were randomly assigned into caffeine group (CG, = 42) receiving 200 mg caffeine pill or placebo group (PG, = 17). OCTA scans were repeated at 60 and 120 min after intervention. VD was measured with Advanced Retina Imaging (ARI) network software (Carl Zeiss Meditec, Dublin, CA) for superficial capillary plexus (SCP) and deep capillary plexus (DCP). SBP/DBP readings were recorded before each imaging session. Ordinary one-way analysis of variance (ANOVA) of each group was performed using GraphPad Prism Version 9.3.0. Both groups had comparable demographics and OCTA parameters at baseline. Two hours after intervention, the CG had a significantly higher SBP (123 ± 7 mmHg) and DBP (81 ± 5 mmHg) compared to the control group (118 ± 7 mmHg, 77 ± 6 mmHg) ( value = 0.012, 0.023). Regarding the OCTA VD metrics, there were no significant differences in VD between the caffeine and placebo groups, regardless of whether the scans were centered on the macula or ONH. Additionally, the comparison across different OCTA scan modalities, specifically the 3 × 3 mm and 6 × 6 mm scans, showed no discernible differences among groups. In conclusion, 200 mg of caffeine elevated blood pressure after 2 h but did not impact the retinal VD. This underscores the intricate relationship between caffeine, blood pressure, and retinal vascular dynamics, prompting further exploration of their implications for ocular health, especially in subjects with vascular disease.
咖啡因是全球消费最广泛的精神活性药物,与包括视网膜在内的各个器官的血管变化有关。研究人员报告称,视网膜会因咖啡因而出现血管收缩,尽管关于其影响的数据仍然有限且有些相互矛盾。需要进一步研究来阐明咖啡因对视网膜血管的具体影响及其对眼部健康的潜在影响。为了研究200毫克咖啡因对收缩压和舒张压(SBP和DBP)以及通过光学相干断层扫描血管造影(OCTA)评估的视网膜血管密度(VD)的影响。在59名低咖啡因摄入的健康使用者(每日咖啡因摄入量<136毫克)中进行了一项前瞻性随机、双盲、安慰剂对照、经机构审查委员会批准的研究。获取了以黄斑为中心的基线3×3和6×6毫米OCTA扫描以及以视神经乳头(ONH)为中心的6×6毫米扫描。参与者被随机分为接受200毫克咖啡因片的咖啡因组(CG,n = 42)或安慰剂组(PG,n = 17)。干预后60分钟和120分钟重复进行OCTA扫描。使用高级视网膜成像(ARI)网络软件(卡尔·蔡司医疗技术公司,加利福尼亚州都柏林)测量浅表毛细血管丛(SCP)和深层毛细血管丛(DCP)的VD。在每次成像前记录SBP/DBP读数。使用GraphPad Prism 9.3.0版本对每组进行普通单因素方差分析(ANOVA)。两组在基线时的人口统计学和OCTA参数具有可比性。干预两小时后,与对照组(118±7 mmHg,77±6 mmHg)相比,咖啡因组的SBP(123±7 mmHg)和DBP(81±5 mmHg)显著更高(P值= 0.012,0.023)。关于OCTA的VD指标,无论扫描是以黄斑还是ONH为中心,咖啡因组和安慰剂组之间的VD均无显著差异。此外,不同OCTA扫描模式(特别是3×3毫米和6×6毫米扫描)之间的比较显示,各组之间没有明显差异。总之,200毫克咖啡因在2小时后会升高血压,但不会影响视网膜VD。这凸显了咖啡因、血压和视网膜血管动力学之间的复杂关系,促使人们进一步探索它们对眼部健康的影响,特别是在患有血管疾病的受试者中。